Cranbury facility clears FDA inspection with VAI status Biocon Ltd received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US FDA for its facility in New Jersey. The EIR, released 30 days after inspection, indicates facility GMP compliance. The FDA classified the inspection as VAI, allowing continued sale of approved drugs and new approvals, despite found violations. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.